The number of registration actions in the field of state registration of rights to real estate in the first quarter of 2024 by 38%, and in the field of business – by 23%, said the head of the Office of counteraction to raiding of the Ministry of Justice Viktor Dubovik.
“Starting from 2020, I am of the opinion that the number of registration actions is one of the important indicators of economic activity in the state. Because the majority of registration actions are revenues to the budget in the form of administrative fees, the emergence of new rights and obligations of citizens and businesses, as well as the presence of demand for the services of notaries and state registrars,” his words are quoted on the website of the Ministry of Justice.
Dubovik specified that for the first three months of 2024 was made 2 million 605.73 thousand registration actions on the real estate and 263.48 thousand – on business, while for the same period in 2023 – respectively 1 million 887.60 thousand and 214.26 thousand.
At the same time, according to his data, the number of complaints received by the Office in the field of real estate increased even more significantly – up to 699 from 290 in the first quarter of last year, while in the business sector the situation, on the contrary, improved: the number of complaints decreased to 115 from 119.
Domestic pharmaceutical manufacturers hope to simplify the procedure and conditions for state registration of active pharmaceutical ingredients (API), which will allow maintaining the volume of drug production in conditions of API shortage, said President of the Association of Manufacturers of Medications of Ukraine (AMMU) Petro Bahriy.
“At one of the meetings in the Ministry of Health, it was decided to simplify the procedure and conditions for state registration of APIs that are part of all medicines, due to the aggravation of the problems of supplying raw materials for the production of drugs to Ukraine due to the introduction of restrictions on export by main suppliers (China, India), in case of replacement of the API manufacturer for the registration of alternative API suppliers in order to avoid a shortage of necessary medicines,” he said in an exclusive interview with Interfax-Ukraine.
The head of the AMMU also noted that domestic pharmaceutical manufacturers hope that the possibilities of using mechanisms of state guarantees, state orders and state reserves for the procurement of medicines will be considered.
At the same time, Bahriy believes that one of the real steps of the state, which would allow solving the problem of the deficit of imported APIs, could be an appeal by the Ukrainian embassies to the governments of the countries in which APIs are produced.
“We need to consider real steps. This can be help from our embassies, which can appeal to the governments of the states where APIs are produced, for example, China or India, so that they somehow pay attention to Ukraine, increase quotas. Although we understand that the effect of this is unlikely will take place, since the United States, the EU, and the whole world, which is in line, turn to these governments,” he said.
